Multiple Choice
Interleukin-2 (IL-2) is used as adjuvant therapy for a patient with metastatic renal cell carcinoma. The nurse teaches the patient that the purpose of therapy with this agent is to
A) protect normal kidney cells from the damaging effects of chemotherapy.
B) enhance the patient's immunologic response to tumor cells.
C) stimulate malignant cells in the resting phase to enter mitosis.
D) prevent the bone marrow depression caused by chemotherapy.
Correct Answer:

Verified
Correct Answer:
Verified
Q25: A patient with a large stomach tumor
Q26: In teaching about cancer prevention to a
Q27: While being prepared for a biopsy of
Q28: The nurse has identified the nursing diagnosis
Q29: The nurse teaches a patient with cancer
Q31: During a routine health examination, a 30-year-old
Q32: External-beam radiation is planned for a patient
Q33: A chemotherapeutic agent known to cause alopecia
Q34: A patient receiving head and neck radiation
Q35: A with tumor lysis syndrome (TLS) is